Publicacións nas que colabora con Pablo Aguiar Fernández (23)

2024

  1. Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models

    International Journal of Pharmaceutics, Vol. 652

  2. Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics

    International Journal of Pharmaceutics, Vol. 662

  3. Quantitative brain [18F]FDG PET beyond normal blood glucose levels

    NeuroImage, Vol. 300

2023

  1. A murine model of BSCL2-associated Celia's encephalopathy

    Neurobiology of Disease, Vol. 187

2022

  1. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

2021

  1. Biodistribution of 68/67Ga-radiolabeled sphingolipid nanoemulsions by pet and spect imaging

    International Journal of Nanomedicine, Vol. 16, pp. 5923-5935

  2. Correction to: Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer? (European Radiology, (2021), 31, 6, (4156-4165), 10.1007/s00330-020-07507-z)

    European Radiology

  3. Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in Rats

    Molecular Imaging and Biology, Vol. 23, Núm. 3, pp. 350-360

  4. Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?

    European Radiology, Vol. 31, Núm. 6, pp. 4156-4165

  5. POU1F1 transcription factor induces metabolic reprogramming and breast cancer progression via LDHA regulation

    Oncogene, Vol. 40, Núm. 15, pp. 2725-2740

2020

  1. -FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage

    Molecular Pharmaceutics, Vol. 17, Núm. 12, pp. 4667-4675

  2. 3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease

    Biomedicines, Vol. 8, Núm. 12, pp. 1-19

  3. Gastrointestinal tracking and gastric emptying of coated capsules in rats with or without sedation using CT imaging

    Pharmaceutics, Vol. 12, Núm. 1

  4. PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 154, pp. 330-337

  5. Periodontitis and vascular inflammatory biomarkers: an experimental in vivo study in rats

    Odontology, Vol. 108, Núm. 2, pp. 202-212

2019

  1. Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal model

    International Journal of Pharmaceutics, Vol. 572

  2. Porphyromonas gingivalis lipopolysaccharide-induced periodontitis and serum amyloid-beta peptides

    Archives of Oral Biology, Vol. 99, pp. 120-125

  3. Prediction of Alzheimer's disease dementia with MRI beyond the short-term: Implications for the design of predictive models

    NeuroImage: Clinical, Vol. 23

  4. Staging the cognitive continuum in prodromal Alzheimer's disease with episodic memory

    Neurobiology of Aging, Vol. 84, pp. 1-8

2018

  1. Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model

    International Journal of Pharmaceutics, Vol. 549, Núm. 1-2, pp. 335-342